Viewing Study NCT03808259


Ignite Creation Date: 2025-12-24 @ 3:05 PM
Ignite Modification Date: 2025-12-28 @ 10:20 AM
Study NCT ID: NCT03808259
Status: COMPLETED
Last Update Posted: 2025-04-27
First Post: 2019-01-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate the Different Modes of (S) Ketamine Administration in Healthy Participants
Sponsor: Janssen Research & Development, LLC
Organization:

Study Overview

Official Title: A Randomized, Participant- and Investigator Blind, Double Dummy, Placebo- and Comparator-controlled, Single Ascending Dose and Parallel-group Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Different Modes of (S) Ketamine Administration in Healthy Participants
Status: COMPLETED
Status Verified Date: 2025-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of different modes of (S) ketamine administration in healthy participants.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
2018-003435-30 EUDRACT_NUMBER None View
54135419EDI1001 OTHER Janssen Research & Development, LLC View